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SUMMARY
Stem/progenitors have been identified intrahepatically in canals of Hering and extrahepatically in
glands of the biliary tree. Glands of the biliary tree (peribiliary glands: PBGs) are tubulo-alveolar
glands with mucinous and serous acini, located deep within intrahepatic and extrahepatic bile
ducts. We have shown that biliary tree stem/progenitors (BTSCs) are multipotent, giving rise in
vitro and in vivo to hepatocytes, cholangiocytes or pancreatic islets. Cells with the phenotype of
BTSCs are located at the bottom of the PBGs near the fibromuscular layer. They are
phenotypically heterogeneous expressing transcription factors and surface and cytoplasmic
markers for stem/progenitors of liver (e.g. SOX9/17), pancreas (e.g. PDX1) and endoderm (e.g.
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SOX17, EpCAM, NCAM, CXCR4, Lgr5, OCT4), but not for mature markers (e.g. albumin,
secretin receptor, or insulin). Subpopulations co-expressing liver and pancreatic markers (e.g.
PDX1+/SOX17+), are EpCAM±, and are assumed to be the most primitive of the BTSC
subpopulations. They give rise to descendents undergoing a maturational lineage process from the
interior to the surface of ducts and varying in mature cells generated: pancreatic cells in hepato-
pancreatic ducts; liver cells in large intrahepatic bile ducts; and bile duct cells along most of the
biliary tree. We hypothesize that there is ongoing organogenesis throughout life with BTSCs
giving rise to hepatic stem cells in the canals of Hering and to committed progenitors within the
pancreas. The BTSCs are likely to be central to normal tissue turnover and injury repair and to be
key elements in the pathophysiology of liver, pancreas and biliary tree diseases including
oncogenesis.
Keywords
multipotent stem cells; endoderm; peribiliary glands; biliary tree; pancreas; liver; Secretin
Receptor; insulin; albumin
INTRODUCTION
The biliary tree is a complex 3-dimensional network of interconnected ducts of increasing
diameter from liver to intestine (Roskams et al., 2004). This network can be subdivided into
two portions: the intrahepatic bile ducts (IHBDs) and the extrahepatic bile ducts (EHBDs).
The EHBDs consist of the left and right hepatic ducts, the common hepatic duct, the
gallbladder with the cystic duct, the bile duct (choledochus) and the hepatopancreatic
ampulla. The hepatopancreatic ampulla drains into the duodenum via the Papilla of Vater.
IHBDs start at the ductular-canalicular junction with the canals of Hering and continue with
bile ductules, interlobular, septal, area and segmental ducts. Area and segmental ducts are
considered large intrahepatic bile ducts, while septal ducts represent an intermediate link
between the large and interlobular biliary system (Nakanuma et al., 1997). Large and septal
IHBDs have several morphological/histological aspects and a embryological origin in
common with EHBDs (Nakanuma et al., 1997).
From a histological point of view, a unique feature that joins the large intrahepatic bile ducts
and the extrahepatic biliary system is the presence of glands in the duct walls. In the
scientific literature, these glands are currently named peribiliary glands (PBGs) (Nakanuma
et al., 1997) but, in the latest version of nomina anatomica, the term “glands of bile duct” is
adopted. Here, we will refer to them as (peri-)biliary glands (or biliary tree glands) and the
abbreviation “PBGs” will be used. PBGs are tubulo-alveolar glands with mucinous and
serous glandular acini located in the deeper tissue of the bile duct walls and communicating
with the duct lumen (Nakanuma et al., 1997).
From an embryological point of view, the biliary system shares a common origin with
ventral pancreas (Nakanuma, 2010). A common stem/progenitor for liver, bile duct system,
and pancreas exists at earlier stages of development, when the anterior definitive endoderm
is forming the foregut (Lemaigre, 2009, Si-Tayeb et al., 2010, Wandzioch and Zaret, 2009,
Zong and Stanger, 2011). The extrahepatic biliary tract originates directly from a portion of
the ventral endoderm deriving from a pancreatobiliary stem/progenitor expressing PDX1
and SOX17 (Roskams and Desmet, 2008, Spence et al., 2009). The segregation of
pancreatic and biliary precursors depends on SOX17; the primitive multipotent precursors
are SOX17+/PDX1+ and give rise to SOX17+/PDX1− extrahepatic biliary cells and
SOX17−/PDX1+ pancreatic cells (Spence et al., 2009). The endodermal proliferation
occurring at the porta hepatis is actually considered the common phenomena giving rise to
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large (area and segmental) intrahepatic bile ducts. By contrast, the interlobular bile duct
formation during the early phase of embryologic development derives from the
differentiation of hepatic stem cells within the ductal plates, and their descendents,
hepatoblasts, located closely to the forming portal tract and is driven by the appearance of
SOX 9 expression (Zhang et al., 2008, Antoniou et al., 2009, Furuyama et al., 2010).
The canals of Hering have long been proposed to be a stem cell niche in postnatal livers
(Alison et al., 1996, Schmelzer et al., 2007, Zhang et al., 2008, Gaudio et al., 2009, Okabe et
al., 2009, Spee et al., 2010). They have been shown recently to derive from the ductal plates
of fetal and neonatal livers (Zhang et al., 2008). In these ductal plates or canals of Hering are
multipotent hepatic stem cells (HpSCs) that give rise to hepatoblasts, that are, in turn, bi-
potent stem cells able to differentiate in vivo and in vitro to mature hepatocytes and
cholangiocytes (Schmelzer et al., 2006, Schmelzer et al., 2007, Zhang et al., 2008, Wang et
al., 2010, Turner et al., 2011).
The cell lineages within and along the biliary tree have not been investigated. So, it is
unknown how many there are or their orientation. Nor has it been clarified whether there are
alternative stem cell niches furnishing the biliary lineage of the bile ducts distal to the
interlobular ones. It was recently shown (Furuyama et al., 2010) that adult intestinal cells,
hepatocytes and pancreatic acinar cells are derived from SOX9-expressing stem/progenitors
located throughout the biliary and pancreatic ductal epithelia suggesting interdependence
between the structure and homeostasis of endodermal organs and with SOX9 expression
being linked to stem/progenitor cell status. However, a more recent study (Carpentier et al.,
2011) indicates that some of these findings are suspect, because the method of marking the
cells for lineage tracing using Cre-Lox technologies was found to induce SOX9 expression;
therefore, the findings using these technologies could have resulted in artifacts.
Recently, we have described the possibility to isolate multipotent biliary tree stem/
progenitor cells (BTSCs) from human fetal and adult extrahepatic bile ducts (Cardinale et
al., 2011). Those cells are located in situ in glands of biliary tree and are able, in vitro and in
vivo, to differentiate into hepatocytes, cholangiocytes and pancreatic endocrine cells. We
have not yet to assess whether they can also give rise to pancreatic acinar cells.
Accordingly, the aim of the present paper is to furnish a detailed characterization of the
presence of progenitor-like cells (biliary tree stem/progenitor cells: BTSCs) with a
endoderm-like phenotype located in glands (PBGs) along extrahepatic and intrahepatic bile
duct system of adult human organs, to confirm their origin from foetal structures and to




Fetal livers and biliary tree tissue were provided by the Department of Gynecology of
Sapienza University of Rome from fetuses of 18–22 week gestational age, and that were
obtained from elective terminations of pregnancy. Informed consent was obtained from
pregnant woman for use of the tissues for research purposes, protocols received Institutional
Review Board approval, and processing was compliant with Good Manufacturing Practice.
Extra-hepatic bile ducts (EHBD) were dissected from liver parenchyma. In particular, we
included in this study: fetal gallbladder (N=3) and fetal common hepatic duct (N=3).
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Human biliary, liver and pancreatic tissues were obtained from cadaveric donors. Livers
were obtained when rejected for transplantation because of steatosis, whereas most of the
biliary tree and pancreatic tissues were obtained because they were not used for
transplantation. All tissues were obtained from the surgical department of Sapienza
University of Rome, Italy. Informed consent was obtained from next of kin for use of the
tissues for research purposes, protocols received Institutional Review Board approval, and
processing was compliant with Good Manufacturing Practice. All of the samples derived
from adults, ages 19–73. We included in this study the following tissues: adult liver
fragments (N=10); adult gallbladder (N=10); adult cystic duct (N=10); adult common
hepatic duct at hepatic hilum (N=5); adult common bile duct (N=5); and adult hepato-
pancreatic ampulla (N=10).
Light Microscopy (LM), Immunohistochemistry (IHC) and Immunofluorescence (IF)
Specimens were fixed in 10% buffered formalin for 2–4 hours, embedded in low-
temperature-fusion paraffin (55–57°C), and 3–4 µm sections were stained with hematoxylin-
eosin. For IHC, sections were mounted on glass slides coated with 0.1% poly-L-lysine.
Sections were hydrated in graded alcohol and rinsed in phosphate-buffered saline (PBS, pH
7.4). Endogenous peroxidase activity was blocked by a 30 min incubation in methanolic
hydrogen peroxide (2.5%). The endogen biotin was then blocked by the Biotin Blocking
System (Dako, code X0590, Glostrup, Denmark) according to the instructions supplied by
the vendor. Antigens were retrieved by applying Proteinase K as suggested by the vendor,
(Dako, code S3020) for 10 min at room temperature. Sections were then incubated overnight
at 4°C with primary antibodies. A complete list of primary antibodies, sources, dilutions and
their role as stem or progenitor marker is reported in Table 1. Samples were rinsed twice
with PBS for 5 min, incubated for 20 min at room temperature with secondary biotinylated
antibody (LSAB+ System-HRP, Dako, code K0690) and then with Streptavidin-HRP
(LSAB+ System-HRP, Dako, code K0690). Diaminobenzidine (Dako) was used as
substrate, and sections were counterstained with hematoxylin or PAS staining.
For Immunofluorescence, non-specific protein binding was blocked by 5% normal goat
serum. Sections were incubated with primary antibodies at room temperature for 1 hour. All
primary antibodies were diluted (1:50) in 1% BSA in PBS-Tween 20 (PBS-T). Then,
sections were washed twice with PBS-T and incubated for 1 h with labeled isotype-specific
secondary antibodies. These included anti-mouse AlexaFluor-488, -546, anti-rabbit
Alexafluor-488. -536, anti-goat AlexaFluor-488, -546, anti-guinea pig-488 (Alexa fluor®,
Invitrogen Ltd, Paisley, UK). They were counterstained with 4′,6-diamidino-2-phenylindole
(DAPI) for visualization of cell nuclei. For all immunoreactions, negative controls consisted
of the primary antibody being replaced with pre-immune serum.
Sections were examined in a coded fashion using the Leica Microsystems DM 4500 B Light
and Fluorescence Microscopy (Weltzlar, Germany) equipped with a Jenoptik Prog Res C10
Plus Videocam (Jena, Germany). LM, IHC and IF observations were processed with an
Image Analysis System (IAS - Delta Sistemi, Roma- Italy) and were performed
independently by two pathologists in a blind fashion. The number of positive cells was
counted in a random, blinded fashion in six non-overlapping fields (magnification × 20) for
each slide. The data are expressed as % positive cells.
In the present paper, several markers of stem, progenitor and mature cells has been used; in
particular, the markers have been considered as following (see also Table 1): i) OCT4,
FOXa2, CXCR4: markers of definitive endoderm (Zaret and Grompe, 2008); ii) PDX1/
SOX17 (co-expression): markers of bilio-pancreatic progenitors iii) PDX1 (alone): marker
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of pancreatic progenitors; iv) SOX17 (alone): marker of biliary progenitors (Spence et al.,
2009); v) Lgr5: marker of intestinal stem cells (Schepers et al., 2011); vi) SOX9, EpCAM,
NCAM are wider markers which are expressed by definitive endoderm, bilio-pancreatic
progenitor, hepatic stem cells; vii) insulin, albumin, HepPar-1, Secretin Receptor, CK19,
CK7 are markers of mature cells (β-pancreatic cells, hepatocytes and cholangiocytes)
(Turner et al., 2011).
For morphometric analysis, the surface occupied by PBGs was obtained in six non-
overlapping fields (magnification ×10) for each slide and measured as volume occupied by
glandular acini (µm2). In Table 2, the average of mass occupied by endoderm-like/
progenitor-like cells (in brackets) has been calculated as PBG mass (average) * % of
PDX1+/SOX19+ cells (average). In order to help the reader, data are summarized by a semi-
quantitative score as previously elsewhere (Glaser et al., 2009b): − < 1%; +/− = 1–5%; + =
5–30%; ++ = 30–50%; +++ > 50%.
RESULTS
Extrahepatic and intrahepatic bile ducts in fetal tissues (Figure 1)
We examined gallbladders and common hepatic ducts from foetuses of 18–22 weeks
gestational age (N=3). In common hepatic ducts, the bud of PBGs is observed as a small
evagination of the surface epithelium (Figure 1A). At this stage, mucin-producing cells are
not present (not shown). Biliary epithelial cells and PBG cells are diffusely positive for
endodermal stem/progenitor markers, located primarily at the bottom of the developing
glands (Figure 1A).
We examined livers (N=3) from fetuses of 18–22 week gestational age. At the hilum, large
connective tracts could be observed containing segmental and septal bile ducts with well-
formed ducts consisting of cells co-expressing EpCAM, PDX1, and SOX17 (Figure 1B).
These ducts were continuous with ductal plates located at the interface of liver parenchyma
(arrowheads in B). At this gestational age, no bud of PBGs could be observed at the level of
the intrahepatic biliary tree.
Extrahepatic bile ducts in adults
Phenotype of cells within glands of EHBDs (Figures 2, 3 and 4)—We examined
adult liver fragments (N=10); adult gallbladder (N=10); adult cystic duct (N=10); adult
common hepatic duct at hepatic hilum (N=5); adult common bile duct (N=5); and adult
hepatopancreatic ampulla (N=10).
In hepatopancreatic ampulla, bile duct, common hepatic duct and cystic duct, PBGs were
present in duct walls and were heterogeneous in cellular composition. The distribution of
(peri-) biliary glands along EHBD was not homogeneous: the highest glandular mass could
be observed at hepatopancreatic ampulla where PBGs occupied an average volume of
31056.67 ± 1673.12 µm2 for 10X-field. In common hepatic duct (at hepatic hilum) and in
cystic duct, the PBG mass occupied an average volume of 6251.22 ± 691.15 µm2 and
6867.47 ± 175.54 µm2 respectively (p< 0.01 versus hepatopancreatic ampulla). Finally the
lowest values have been calculated along bile duct (3115.53 ± 543.69 µm2, p< 0.01 versus
other EHBDs).
Extrahepatic bile ducts were composed mostly of cholangiocytes and mucin-producing cells
which together represented more than 60% of the cells of the PBGs. The
immunohistochemical analyses revealed that ≈12% of cells within PBGs expressed surface
markers (EpCAM, NCAM, CXCR4, LGR5) and/or transcription factors (FOXa2, SOX9,
OCT4) typical of endodermal stem cells and progenitors (Figure 2). Immunofluorescence
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protocols revealed that endoderm-like/progenitor-like cells [i.e. PDX1+/SOX17+ (or
FOXa2+] accounted for 11 ± 3.81% of cells within PBGs (Figures 3A and 4, Table 2).
These cells predominantly showed EpCAM expression: EpCAM+/PDX1+/SOX17+ cells
represented 8 ± 2.55% of the cells whereas EpCAM−/PDX1+/SOX17+ cells accounted for 2
± 1% (Figure 3A). However, the most interior of the cells were EpCAM− and transitioned to
EpCAM+ cells with progression towards to the lumen. This suggests that the EpCAM− cells
are giving rise to the EpCAM+ cells, an hypothesis supported also by findings in culture
(Cardinale et al., 2011).
At the level of hepatopancreatic ampulla, the investigation of mature phenotypic markers
indicated that cells in PBGs express markers of goblet cells (PAS+: 37 ± 5.70%), mature
cholangiocytes (secretin receptor+: 27 ± 5.70%), β-islet cells (insulin+: 9.8 ± 3.56%), and,
rarely, of hepatocytes (albumin+, HepPar1+: less than 5%). Moreover, dual
immunostainings with EpCAM and mature cell markers showed that there was a large and
heterogeneous population of intermediate cells (EpCAM+/PAS+, EpCAM+/SR+, EpCAM+/
Insulin+, EpCAM+/Albumin+). These constituted 26 ± 6.52% of cells within PBGs (Figure
3B). Intermediate cells could be interpreted as newly derived cells originating from
endoderm-like/progenitor-like cells (Yoon et al., 2011). Observations from hepatic duct and
cystic duct showed similar results (Figure 4) with the exception of i) the percentage of
insulin+ cells, that was found to be rare (less than 5%, p<0.01 vs hepatopancreatic ampulla;
Table 2), ii) the percentage of HepPar1+ cells (12.2 ± 5.4%), that was higher in comparison
with hepatopancreatic ampulla (less than 1%, p<0.01, Table 2); iii) the presence of
pancreatic progenitor-like cells (i.e. PDX1+/SOX17− cells), which accounted for 13.2 ±
4.44% at the level of hepatopancreatic ampulla while could be rarely individuated in hepatic
ducts (less than 5%, p<0.01).
Gallbladder is devoid of PBGs. However, cells expressing EpCAM, NCAM, CD133,
CXCR4, LGR5, PDX1, and SOX17 were present within the surface epithelium (not shown).
Organization of stem cell niche in PBGs of EHBDs (Figure 5)
Progenitor-like and mature cells showed a typical organization in PBGs (Figure 5).
Glandular acini located deep within duct wall (near the fibromuscular layer) were mostly
composed of cells expressing stem/progenitor cell markers (e.g. EpCAM and PDX1: Figure
5C and F). In parallel, acini located near the surface epithelium were mostly constituted by
cells negative for stem/progenitor cell markers and positive for markers of goblet cells (PAS
+, Figure 5B). Finally, cells with a committed phenotype (e,g, goblet cells or mature
cholangiocytes) were mostly present in acini located in the intermediate portion of glands of
biliary tree (EpCAM+/PAS+: Figure 5A).
The expression of PCNA, a marker of cell proliferation, followed the distribution of stem
cell markers (Figure 3 G–I). PCNA positive cells constitute 14.6 ± 3.50% of cells within
PBGs and are located mostly at the bottom of PBGs. The number of PCNA positive cells
progressively decreases as one moves towards the surface epithelium. At the surface, the
PCNA+ cells are rare (less than 5%).
Intrahepatic bile ducts in adults (Figures 6 and 7)
We examined separately large (area and segmental), medium (septal), interlobular bile ducts
and bile ductules within adult liver parenchyma (N=10). PBGs were found predominantly at
the level of large bile ducts. In these ducts, two types of glands were observed: intramural
and extramural PBGs. The intramural PBGs were positioned inside the duct wall and appear
as shallow evaginations of the bile duct epithelium. Extramural PBGs were located outside
the wall and are composed of PAS-negative cells (Figures 6, 7). At the level of septal bile
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ducts, PBGs can be observed occasionally as small evaginations of the bile duct epithelium.
Finally, interlobular bile ducts are devoid of glands.
The morphometric analysis showed that (peri-)biliary glands of IHBDs accounted for a
restricted area of liver parenchyma mostly located near the hilum (0.72% ± 0.38 of
examined parenchyma). Moreover, the glandular mass occupied an average volume of
2629.21 ± 638.38 µm2 for 10X-field which was significant lower when compared with
hepatopancreatic ampulla, common hepatic ducts and cystic ducts (p<0.01).
In segmental, area and septal bile ducts, PBGs and biliary epithelia contained cells
expressing EpCAM, PDX1, SOX17, NCAM, CD133, CXCR4, and LGR5. Observations on
serial sections (Figure 7) indicated that in intra- and extramural PBGs, PDX1+/SOX17+
(endoderm-like/progenitor-like cells) cells were present accounting respectively for the 8.44
± 2.96% and for 38 ± 10.46% of cells. As regards EpCAM expression, intramural
(peri-)biliary glands were mostly composed of positive cells whereas extramural glandular
cells displayed a faint positivity (Figure 6). Accordingly, extramural PBGs were mostly
composed by endoderm-like/progenitor-like cells in comparison with intramural glands
which, in turn, express higher level of EpCAM (intermediate phenotype).
Moreover, similar to that in the common hepatic duct, intrahepatic PBGs showed (Figures 4
and 7, Table 2): i) a rare percentage of insulin+ cells (less than 1%, p<0.01; Table 2), ii) a
percentage of HepPar1+ cells (14.4 ± 3.78%), that was higher in comparison with
hepatopancreatic ampulla; iii) the amount of pancreatic progenitor-like cells (i.e. PDX1+/
SOX17− cells) which could identified was rare and less than 5%.
Finally, the epithelia of interlobular bile ducts do not show any cells co-expressing EpCAM,
PDX1 and SOX17 (Table 2). Rarely, EpCAM positive cholangiocytes have been found in
interlobular bile ducts.
DISCUSSION
In the present paper, we demonstrated that, in human, glands of the biliary tree (PBGs)
represent niches of cells with classic phenotypic traits of stem/progenitor cells of
endodermal origin with respect to transcription factors, surface and cytoplasmic markers,
and with evidence for proliferation.
Since it is not correct that a cell is defined as a “stem cell” just because of the expression of
certain markers without demonstrating a long term persistence, self-renewal and without a
lineage tracing study, we refer to such cells as “progenitor-like”, or “endoderm-like”.
However, our observations in human tissues should integrated with in vitro demonstration
that (Pdx1+/Sox17+/EpCAM+) cells isolated from biliary tree have long term (in vitro)
persistence, self-renewal and are able to give rise to a more restricted progeny (Cardinale et
al., 2011). Moreover, in the paper by Spence et al., a lineage tracing study has been
performed demonstrating that SOX17/PDX1 positive cells are the bilio-pancreatic
precursors (Spence et al., 2009).
The study of the organization of cells within glands of biliary tree showed that: i) the
progenitor-like cells and transit-amplifying cells were located at the bottom of the glands; ii)
the cells with an intermediate phenotype between progenitor-like cells and mature cells were
found in the middle of the glands; and iii) the fully differentiated cells were in continuum
with the surface epithelium. Cells producing low levels of insulin are found within PBGs,
especially in the hepatopancreatic common ducts, whereas those producing albumin are
found in portions of the biliary tree near to liver. Endoderm-like/progenitor-like cells are
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also found in PBGs intrahepatically within large bile ducts, representing a candidate niche
for the renewal of the intrahepatic cells.
Glands of biliary tree (PBGs) are tubular-alveolar glands composed of serous and mucinous
acini located along extrahepatic and large intrahepatic bile ducts (Nakanuma et al., 1997).
Glandular epithelial cells are resorptive with relevance to the mechanisms of concentration
and resorption of bile constituents from the duct lumina to the surrounding vessels,
including the lymphatics. These glands show some secretory activities (secretion of
mucinous substances) and are also positive for pancreatic digestive enzymes (Terada et al.,
1994).
Recently, we isolated multipotent stem/progenitor cells from fetal and adult extrahepatic
biliary tree tissue. These cells were able in vitro and in vivo to generate mature hepatocytes,
cholangiocytes and β-pancreatic cells (Cardinale et al., 2011). We have yet to test whether
they can give rise to pancreatic acinar cells. In the present paper, we provide a more detailed
description of the anatomical location of the BTSCs, the cellular phenotypes present and
evidence for a maturational lineage process from the interior of the ducts to the luminal
surface.
To assess our aims, several markers of stem, progenitor and mature cells has been evaluated;
OCT4, FOXa2, CXCR4 are typical markers of definitive endoderm (Zaret and Grompe,
2008); biliopancreatic progenitor cells are SOX17+/PDX1+ and give rise to SOX17+/
PDX1− biliary progenitors and SOX17−/PDX1+ pancreatic progenitors (Spence et al.,
2009). Finally, Lgr5 is a recognized marker for intestinal stem cells (Schepers et al., 2011)
while SOX9, EpCAM, NCAM are more diffusely distributed markers which are expressed
by definitive endoderm, bilio-pancreatic progenitor and hepatic stem cells (Turner et al.,
2011).
In PBGs, approximately 10% of the cells co-expressed PDX1, SOX17 and FOXa2, a
phenotype indicative of the early stem cell subpopulation (endoderm-like cells). Moreover,
we showed that glands of biliary tree were also composed by populations of cells with less
primitive phenotypes which were characterized by the loss of FOXa2 and PDX1 expression
(biliary progenitor-like cells) or, alternatively, by the loss of FOXa2 and SOX17 (pancreatic
progenitor-like cells). Both the cell populations maintained the expression of EpCAM which
is a wider expressed marker. Several lines of evidence indicate that EpCAM expression is
tightly regulated and only occurs in case of a temporary need for proliferation and is
immediately downregulated upon terminal differentiation (Trzpis et al., 2007, Maetzel et al.,
2009).
Biliary Tree Stem Cells could represent the remnant in adults of the common stem/
progenitor (PDX1+/SOX17+) for liver, bile duct system and pancreas which exists at earlier
stages of development (Spence et al., 2009) and which is considered to derive from ventral
endoderm (Wandzioch and Zaret, 2009, Zong and Stanger, 2011).
Within the body of the PBGs, we identified the presence of a committed intermediate
(transit-amplifying) compartment in which were present cells co-expressing both stem cell
markers and markers of mature cells: secretin receptor (cholangiocytes), mucins (goblet
cells), insulin (endocrine pancreas) and, rarely, albumin (hepatocytes). The relative
proportion of cells expressing mature cell markers indicative of liver versus bile duct versus
pancreas correlated with the location along the length of the biliary tree. This portion of the
compartment could be descendent of the endoderm-like/progenitor-like cells located at the
base of the glands (Furuyama et al., 2010, Yoon et al., 2011).
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In accordance, PBGs present an organization along the duct wall: cells with an
undifferentiated phenotype (EpCAM± /PDX1+/SOX17+/LGR5+) are situated mostly in the
gland base near the fibromuscular layer. The transit-amplifying progenitor population
(EpCAM+ /PDX1±/SOX17±/LGR5−) are concentrated in the body of the glands
(corresponding to the middle of the duct wall). Finally, mature cells (e.g. cholangiocytes,
goblet cells, hepatocytes, pancreatic cells) are located at the neck of PBGs in strict contact
with the surface epithelium; which mature cell type is found depends on whether the portion
of the biliary tree is near the liver (hepatocytes); in the middle of the biliary tree
(cholangiocytes); or near the duodenum (pancreatic cells and goblet cells). The distribution
of proliferating cells followed a similar gradient; in fact, the number of PCNA-positive cells
was higher at the bottom of glands and decreased with progression towards the lumen.
Interestingly, the cells of the surface epithelium were mostly PCNA negative. Taken
together, these data indicate that PBGs contain progenitor-like cells which normally
proliferate and are responsible for the renewal of the surface epithelium generating mature
cells such as cholangiocytes and goblet cells (in the middle of the biliary tree) or hepatocytes
(near the liver) or islet cells (near the pancreas).
In summary, the endoderm-like/progenitor-like cell compartment within PBGs resembles
the organization of the stem cell niche within intestines. In the intestine, proliferation takes
place at the base of intestinal crypts in which are located LGR5+ stem cells interspersed by
Paneth cells (Pech and Artandi, 2011, Schepers et al., 2011). They give rise to progenitors
produced from stem cells in the crypts (transit-amplifying population) migrate upwards and
fully differentiate towards mature cells. The phenotype of the mature cell (e.g. whether
stomach, duodenum, small intestine or large intestine) depends on the position of the villus
in the anterior to posterior axis along the intestine (Shaker and Rubin, 2010, Sancho et al.,
2003).
In PBGs, particularly those near the hepatopancreatic ampulla, there are individual cells able
to produce insulin. The co-expression of EpCAM by insulin-producing cells seems to
indicate that these elements represent intermediate cells that have partially differentiated. In
mouse, the presence of pancreatic β-cells exhibiting a glucose-stimulated insulin secretion
has already been shown in extrahepatic bile ducts (Dutton et al., 2007, Nagaya et al., 2009).
Moreover, studies in genetically manipulated animals have indicated that the biliary tract is
able to demonstrate pancreatic differentiation (Nakanuma, 2010, Eberhard et al., 2008). In
Hes1−/− mice, biliary epithelia differentiate into endocrine and exocrine cells and form acini
and islet-like structures in the mutant bile ducts (Sumazaki et al., 2004, Fukuda et al., 2006).
In humans, the presence of insulin-producing cells within extrahepatic biliary tract was
unknown until our studies (Cardinale et al., 2011). Clearly future studies must devote
detailed characterization of the biliary tree, especially the hepatopancreatic ampulla, as the
native reservoir of stem cells for pancreatic organogenesis in adults.
In adult human livers, a well-described stem cell niche is located within canals of Hering
(Schmelzer et al., 2007, Zhang et al., 2008, Gaudio et al., 2009, Spee et al., 2010, Turner et
al., 2011). The adult hepatic stem cell niche is derived from the ductal plates of fetal and
neonatal livers (Zhang et al., 2008) and is composed by stem/progenitor cells named
recently human hepatic stem cells (hHpSCs) (Schmelzer et al., 2007, Roskams and Desmet,
2008, Furuyama et al., 2010, Turner et al., 2011).
In normal conditions, hHpSCs are mostly quiescent taking no or minimal part in the renewal
of liver parenchyma which is sustained by the replication of adult hepatocytes within the
lobules and of cholangiocytes in interlobular bile ducts (Fausto, 2004, Gaudio et al., 2009).
However, a recent study by Furuyama et al (Furuyama et al., 2010) showed by a Cre-based
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lineage tracing that hepatocytes are supplied physiologically from Sox9-expressing
progenitors located within Canals of Hering.
In a variety of chronic and acute liver diseases, the proliferation of mature parenchymal liver
cells is impaired by a variety of insults leading to the activation of a secondary proliferative
pathway of hHpSCs and the appearance of reactive ductules (ductular reaction) which
represent tortuous structures with no discernable lumen and composed of progenitor cells,
with highly variable marker profiles (Spee et al., 2010). A number of recent evidence
demonstrated how ductular reaction represents the morphological expression of activation of
resident stem/progenitor cell pool aimed to repair liver damage either through the
replacement of death cells or by driving fundamental repair processes including fibrosis and
angiogenesis (Glaser et al., 2009a, Omenetti et al., 2008). In particular, in the setting of
fibrosis following chronic hepatic injuries, hHpSCs has been demonstrated to be able to
underlie an Epithelial to Mesenchynal Transition (EMT)(Omenetti et al., 2008, Svegliati-
Baroni et al.); however, the exact role of EMT and its contribution in the hepatic
fibrogenesis have not been fully clarified and are still under debate (Wells, 2010).
Beside the well-known niche at the level of Canals of Hering, our results indicate an
additional set, indeed, a large number of cells with the phenotype of endodemal stem/
progenitor cells within PBGs of the large intrahepatic bile ducts both in foetal and adult life
implicating a newly identified reservoir of stem cells for the renewal of the large bile duct
epithelium.
Our observations suggest that these niches are closely related to the ductal plate which has
been recently demonstrated to generate the liver parenchyma during embryogenesis
(Carpentier et al., 2011). This relationship is supported by our observation in fetal tissue in
which progenitors in large bile ducts were continuous with ductal plates which transition
into the canals of Hering (Zhang et al., 2008). Moreover, our observations are in touch with
the hilum to periphery model of bile duct morphogenesis recently proposed by Lemaigre et
associates (Antoniou et al., 2009).
Segmental, area and septal intrahepatic bile ducts share several common features with
EHBDs such as the presence of PBGs (Nakanuma et al., 1997, Terada et al., 1994) and,
interestingly, the presence of endoderm-like/progenitor-like cells that are EpCAM±/PDX1+/
SOX17+/LGR5+. These observations are in accordance with the possibility of isolating
multipotent stem cells from fetal and adult livers of rodents and other mammals (Suzuki et
al., 2002, Yang et al., 2002).
Our observations could also have profound pathophysiologic implications since the PBGs,
as stem cell niches, could play a relevant role in the pathogenesis of inflammatory (primary
sclerosing cholangitis) and neoplastic (cholangiocarcinoma) diseases of the biliary tree.
With respect to this point, the PBGs have morphology and phenotypic traits strongly similar
to intestinal stem cells described by Cleaver and associates (Sancho et al., 2003) and to the
pancreatic duct glands characterized by Bonner-Weir and associates or by Thayer and
associates (Strobel et al., 2010). Thayer and her associates have determined that the
pancreatic duct glands are comprised of progenitors and are sites responding to injuries and
diseases. The morphology and phenotypic traits of the cells of the pancreatic duct glands are
strikingly similar to those of the biliary tree glands. Further study is needed to clarify if the
biliary tree glands and pancreatic duct glands are, in fact, variations on the same entities that
share in the organogenesis process leading to both liver and to pancreas.
A number of recent studies have focused on the role of stem cells in the origins of cancer
(Reya et al., 2001). A large body of current literature deals with the involvement of stem/
progenitors in oncogenesis of the liver (Komuta et al., 2008, Yamashita et al., 2009, Ji et al.,
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2009, Marquardt et al., 2011, Woo et al., 2011). Human hepatic stem cells (hHpSCs) are
actually considered cells of origin of some hepatocarcinoma and intrahepatic
cholangiocarcinoma (Komuta et al., 2008, Yamashita et al., 2009, Ji et al., 2009). They have
demonstrated how stem cell activators such as Wnt/beta-catenin, TGF-beta, Notch and
Hedgehog signaling pathways also expedite liver tumorigenesis (Marquardt et al., 2011,
Woo et al., 2011). Primary liver cancers arise in the context of hepato-biliary diseases of
different aetiologies (Welzel et al., 2007, Cardinale et al., 2010, Tyson and El-Serag, 2011).
As for cells of the pancreatic duct glands (Strobel et al., 2010), those of the PBGs are sites
for increased vulnerability to diseases especially in response to the death of the injured
mature cells or to continued stimuli to achieve a “restitutio ad integrum”, represents the
initial step of the oncogenic process. Similarly cell proliferation and PBG hyperplasia
represent common features associated with the pathologies that affect the large intrahepatic
and the extrahepatic bile ducts, which are currently indicated as risk factors associated to the
development of the cholangiocarcinoma (Cardinale et al., 2010). Our histological
observation of stem cell niches within biliary tree suggests the possibility that they could be
involved in cholangiocarcinoma development. In particular, our results suggest that
endoderm-like stem cells within PBGs could represent the cells of origin of mucin-
producing intrahepatic cholangiocarcinomas; this histological subtype of
cholangiocarcinoma is characterized by mucin-producing cells and typically arises at the
hepatic hilum in the context of intrahepatic segmental bile ducts (Blechacz et al., 2011); our
data demonstrated how PBGs contain mucin-producing cells and their location overlaps with
the sites in which the mucinous cholangiocarcinoma typically occurs; moreover,
cholangiocarcinomas express several markers that are in common with PBG cells such as
EpCAM, OCT4, CD133 (Komuta et al., 2008); finally, hilar cholangiocarcinoma has been
correlated with definite risk factors (such as primary slerosing cholangitis, liver fluke
infection) which determinate the proliferation of PBGs (Nakanuma et al., 2011, Tyson and
El-Serag, 2011). The cancer cell of origin has great importance in tumor cell fate and
pathology; the activation of the same genetic/epigenetic mutation in different cellular
compartment of a given organ may have profound implication in malignant potential. The
identification of the cells of origin of cancers has as prerequisite the characterization of the
normal cellular hierarchy within a given tissue and the study of stem cells niches. The most
primitive cells, stem cells, are candidates for targets of transformation because of their self-
renewal and longevity, which would allow the sequential accumulation of genetic or
epigenetic mutations required for oncogenesis (Visvader, 2011). Further studies on
cholangiocarcinoma are needed to test the possibility that this tumour or its histological
subtypes could derive from cells within PBGs.
In summary, the main and original findings of the present study indicate that in humans: i)
glands of extrahepatic bile ducts (peribiliary glands: PBGs) represent the niche of
endoderm-like and progenitor-like cells (biliary tree stem/progenitor cells: BTSC); ii) this
niche follows the model of intestinal stem cell niche: proliferating cells and cells with a
more primitive phenotype are located at the bottom of the gland, cells with an intermediate
phenotype are placed in the middle of the gland and fully differentiated cells are in
continuum with the surface epithelium; iii) insulin producing cells are located within PBGs
of human adult extrahepatic bile ducts; iv) in intrahepatic biliary tree, endoderm-like and
bilio-pancratic progenitor-like cells are present and located in PBGs of large bile ducts
representing a new niche for the renewal of biliary epithelium; v) the endodermal stem/
progenitor-like cells in the adult seem to be the remnant of endoderm and bilio-pancratic
progenitor cells that in fetal life determinate the formation of biliary tree. Our data have
implications for the knowledge on biliary tree development, physio-pathology and
carcinogenesis and open novel scenarios in regenerative medicine, since the extrahepatic
biliary tree could be a reservoir of stem cells useful in cell therapy programs for liver, biliary
tree, and pancreas (e.g. diabetes).
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A) 18–22 weeks old, fetal common hepatic duct (serial sections). The epithelia of fetal
common hepatic duct are comprised of hepato-pancreatic progenitors (EpCAM ±, PDX1+,
SOX17+, Lgr5+). Small evaginations of the epithelium, representing the bud of
(peri-)biliary glands, were observed (arrows). The bud of PBGs are comprised of
endodermal progenitors (arrows) that are located mostly at the bottom of the glands (see the
arrow in the magnified image of cells stained with EpCAM). B) In 18–22 weeks old fetuses,
the large intrahepatic bile duct can be found at the hilum. These ducts are composed mostly
of endodermal (EpCAM±/PDX1+/SOX17+/Lgr5+) stem/progenitor cells (arrows). Scale
Bar= 50µm.
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Phenotype of glands within extrahepatic bile ducts. A) In haematoxylin-eosin stains,
(peri-)biliary glands are tubulo-alveolar glands located in the lamina propria of duct walls
(arrows). Immunohistochemistry showed the presence of Cytokeratin-19 (CK 19)+ cells in
the surface epithelium (cholangiocytes) and in the PBGs (arrows). B)
Immunohistochemistry for nuclear transcription factors and surface markers characterizing
endodermal stem cells. Upper panels: cells within PBGs express markers typical of
endodermal stem cells such as FOXa2, CXCR4, OCT4 (arrows). Lower panels: PBGs are
composed of cells expressing typical markers of intestinal stem cell (LGR5) and hepatic
stem cell such as EpCAM, NCAM, SOX9. Scale Bar= 50µm.
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Triple/double immunofluorescence staining demonstrating the presence of endoderm-like
and progenitor-like cells (BTSCs) and cells with an intermediate phenotype within PBGs. A)
EpCAM ± /PDX1+/SOX17+(or FOXa2+) cells were present in PBGs (arrows) representing
≈10% of the PBG cells. B) Double immunofluorescence staining indicated the presence of a
population of EpCAM+ cells which co-express markers of mature cells such as secretin
receptor (cholangiocyte lineage), insulin (β-pancreatic cells) and, rarely, albumin
(hepatocyte lineage). This intermediate compartment represents ≈ 20% of cells of PBGs at
hepato-pancreatic ampulla. Scale Bar= 50µm.
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Demonstration of the distinction in mature marker fate as one progresses along the biliary
tree. A–B) Double immunofluorescence for PDX1 and SOX19 and immunohistochemistry
for Cytokeratin 19, HepPar-1 and Insulin at the level of hepatopancreatic ampulla (A) and
common hepatic/large intrahepatic bile ducts (B). Scale Bar= 50µm.
Several differences could be noted: the presence of pancreatic progenitor-like cells (i.e.
PDX1+/SOX17− cells, green arrows) and insulin+ cells was higher near the
hepatopancreatic ampulla when compared with hepatic/large intrahepatic bile ducts; by the
contrast, the presence of HepPar+ cells was higher in common hepatic/large intrahepatic bile
ducts in comparison with hepato-pancreatic ampulla (see also Table 2).
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Gradient in the expression of stem cell markers and of the proliferation of PBGs cells. A–C)
Immunohistochemistry for EpCAM counterstained with PAS. Glandular element just
beneath the surface epithelium (see magnification in B) are mostly EpCAM negative and
PAS positive (goblet cells); by contrast, acini deeply located near the fibromuscular layer
(see magnification in C) are composed of cells that are mostly EpCAM+ and PAS negative
(arrows) or by EpCAM+/PAS+ cells (arrowhead). D–F) Immunohistochemistry for PDX1.
PDX1+ cells are mostly situated deeply within duct walls (see magnification in F: arrows).
PBGs near the surface epithelium are occasionally PDX1+ (arrow in E). G–I)
Immunohistochemistry for PCNA. Proliferating cells are mostly present in glandular
elements located near the fibromuscular layer (I: arrows). Few cells are positive in more
superficial acini. Notably, surface epithelial cells are mostly negative for PCNA. Scale Bar=
50µm.
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Morphological aspects of glands within intrahepatic bile ducts. A–B) Haematoxylin-eosin
and PAS stains. PBGs were predominantly found at the level of large bile ducts; in these
ducts, two types of (peri-)biliary glands could be observed: intramural PBGs (arrows) were
positioned inside the duct wall and appeared as shallow evaginations of the bile duct
epithelium; extramural PBGs (box) were located outside the wall and were composed of
PAS negative cells. C–D) Immunohistochemistry for CK19 and EpCAM showed the
presence of positive cells in the surface epithelium, intra- (arrows) and extramural (box)
PBGs. Scale Bar= 50µm.
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Immunohistochemistry for PDX1, SOX17 and Lgr5 in intrahepatic bile ducts. A) In large
intrahepatic bile ducts, the surface epithelium and the intramural PBGs contain endoderm-
like and progenitor-like cells (PDX1+/SOX+/Lgr5+ cells) as indicated in seriated sections
(arrows). B) Extramural (peri-)biliary glands are composed mostly of endoderm-like and
progenitor-like cells which co-express specific markers (PDX1+/SOX+/Lgr5+). Notably,
PDX1+/SOX19− cells were rarely found. Scale Bar= 50µm.
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Table 1
List of used antibodies
Name Source Catalog
Number
Dilution Role as marker for stem and
progenitor cells
OCT4 Abcam Ab19857 1:500 Embryonic stem cell
FOXa2 Abcam Ab40874 1:500 Definitive endoderm
CXCR4 Abcam 1:100 Definitive endoderm
Bilio-pancreatic progenitors
PDX1 Santa Cruz SC-25403 1:50 Pancreatic progenitors
SOX17 Santa Cruz Sc-17355 1:50 Biliary progenitors
SOX9 Chemicon Ab 5535 1:50 Definitive endoderm
Bilio-pancreatic progenitors
Hepatic stem cell
Lgr5 Santa Cruz 1:50 Intestinal stem cell
CD326 / EpCAM Santa Cruz sc-59782 1:50 Definitive endoderm
Bilio-pancreatic progenitors
Hepatic stem cell
CD56 / NCAM Santa Cruz SC-7326 1:50 Bilio-pancreatic progenitors
Hepatic Stem Cells
Insulin DAKO IS002 1:100 β-pancreatic cells
HepPar-1 DAKO M7158 1:50 Mature Hepatocyte
Albumin DAKO F0117 1:50 Mature Hepatocyte
CK19 (cytokeratin 19) DAKO M0888 1:100 Biliary Cytokeratin
CK7 (cytokeratin 7) DAKO M7018 1:100 Biliary Cytokeratin
Secretin receptor Santa Cruz SC-26633 1:50 Mature cholangiocytes
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